HIV dementia

Mattson MP, Haughey NJ, Nath A (2005) Cell death in HIV dementia. Cell Death Differ 12(Suppl 1) 893-904... [Pg.28]

McArthur JC (2004) HIV dementia an evolving disease. J Neuroimmunol 157(l-2) 3-10 McArthur JC, Hoover DR, BaceUar H, MUler EN, Cohen BA, Becker JT, Graham NM, McArthur JH, Seines OA, Jacobson LP et al (1993) Dementia in AIDS patients incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 43(ll) 2245-2252 McManus CM, liu JS, Hahn MT, Hua LL, Brosnan CE, Berman JW, Lee SC (2000) Differential induction of chemokines in human microgUa by type I and II interferons. GUa 29(3) 273-280 McQuibban GA, Butler GS, Gong JH, BendaU L, Power C, Clark-Lewis I, OveraU CM (2001) Matrix metaUoproteinase activity inactivates the CXC chemokine stromal ceU-derived factor-1. J Biol Chem 276(47) 43503 3508... [Pg.28]

Moore DJ, Masliah E, Rippeth JD, Gonzalez R, Carey CL, Cherner M, Ellis RJ, Achim CL, Marcotte TD, Heaton RK, Grant I (2006) Cortical and subcortical neurodegeneration is associated with HIV neurocognitive impairment. Aids 20(6) 879-887 Nath A (2002) Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis 186(Suppl 2) S193-S198... [Pg.28]

Wong MH, Robertson K, Nakasujja N, Skolasky R, Musisi S, Katabira E, McArthur JC, Ronald A, Sacktor N (2007) Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa. Neurology 68(5) 350-355... [Pg.32]

Fischer-Smith T, Croul S, Sverstiuk AE, Capini C, L Heureux D, Reguher EG, Richardson MW, Amini S, MorgeUo S, Khalili K, Rappaport J (2001) CNS invasion by CD14-I-/CD16-I- peripheral blood-derived monocytes in HIV dementia perivascular accumulation and reservoir of HIV infection. J Neurovirol 7(6) 528-541... [Pg.111]

Liu Y, Tang XP, McArthur JC, Scott J, Gartner S (2000) Analysis of human immunodeficiency virus type 1 gpl60 sequences from a patient with HIV dementia evidence for monocyte trafficking into brain. J Neurovirol 6(Suppl 1) S70-S81 Liu H, Dow EC, Arora R, Kimata JT, Bull LM, Arduino RC, Rice AP (2006) Integration of human immunodeficiency virus type 1 in untreated infection occurs preferentially within genes. J Virol 80(15) 7765-7768... [Pg.113]

DhUlon NK, Williams R, CaUen S, Zien C, Narayan O, Buch S (2008) Roles of MCP-1 in development of HIV-dementia. Front Biosd 13 3913-3918... [Pg.242]

Nath A (2002) Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis 186(Suppl. 2) S193-198... [Pg.247]

Roux KH, Taylor KA (2007) AIDS virus envelope spike structure. Curr Opin Struct Biol 17 244-252 Sacktor N, Haughey N, Cutler R, Tamara A, Turchan J, Pardo C, Vargas D, Nath A (2004) Novel markers of oxidative stress in actively progressive HIV dementia. J Neuroimmunol 157 176-184 Samson M, LaRosa G, Libert F, Paindavoine P, Detheux M, Vassart G, Parmentier M (1997) The second extraceUular loop of CCR5 is the major determinant of ligand specificity. J Biol Chem 272 24934-24941... [Pg.248]

Marcario JK, Riazi M, Adany I, Kenjale H, Fleming K, Marquis J, Nemon O, Mayo MS, Yankee T, Narayan O, Cheney PD (2008) Effect of morphine on the neuropathogenesis of SlVmac infection in Indian Rhesus Macaques. J Neuroimmune Pharmacol 3 12-25 Mattson MP, Haughey NJ, Nath A (2005) CeU death in HIV dementia. Cell Death Differ 12 893-904 Mayne M, Bratanich AC, Chen P, Rana F, Nath A, Power C (1998) HlV-1 tat molecular diversity and induction of TNF-alpha implications for HIV-induced neurological disease. Neuroimmunomodulation 5 184-192... [Pg.372]

Ferrarese C., Aliprandi A., Tremolizzo L., Stanzani L., De Micheli A., Dolara A., and Frattola L. (2001). Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology 57 671-675. [Pg.193]

Pocemich C. B., Sultana R., Mohmmad-Abdul H., Nath A., and Butterfield D. A. (2005). HIV-dementia, Tat-induced oxidative stress, and antioxidant therapeutic considerations. Brain Res... [Pg.237]

Alisky JM. Could cholinesterase inhibitors and memantine alleviate HIV dementia J Acquir Immune Defic Syndr 2004 38 1-3. [Pg.639]

In a busy clinical practice setting, the simplest neui o-psychological test to diagnose HIV dementia is ... [Pg.616]

Van der Meer P, Ulrich AM, Gonzalez-Scarano F, Lavi E (2000) Immunohistochemical analysis of CCR2, CCR3, CCR5, and CXCR4 in the human brain Potential mechanisms for HIV dementia. Exp Mol Pathol 69 192-201. [Pg.204]

Liu Y Tang XP, McArthur JC, Scott J, Gartner S (2000) Analysis of human immunodeficiency vims type 1 gpl60 sequences from a patient with HIV dementia Evidence for monocyte trafficking into brain. J Neurovirol 6(Suppl 1) S70-81. [Pg.309]

Not only is the CD4 T cell count higher, but also the mean time from diagnosis of HIV dementia to death has extended from 6 months to 44 months, and the clinical presentation has changed with more cortical manifestations as compared with previously reported subcortical presentations (Brew, 2004). HAD appears to be more stable of late, and does not progress as rapidly (McArthur et al., 2003). Some patients may have residual neurological deficits which are irreversible and do not improve with additional ART (Saksena and Smit, 2005). [Pg.606]

More focused neuropsychological batteries have been developed for this purpose, such as those listed in Table 41.2. The HIV Dementia Scale is also a nsefnl tool and only takes five minutes to administer and score (Power et al., 1995). It is important to remember that interpretation of nenropsycholog-ical tests also requires attention to patient demographics snch as language skills, presence of comorbid conditions, substance abuse, and concomitant nse of psychotropic medications. [Pg.607]

The pathological snbstratum of HIV dementia is referred to as HIV encephalitis (HIVE). HIVE is a disseminated multifocal process characterized by the presence of multinucle-ated giant cells of macrophage/microglial origin microglial nodules diffuse astrocytosis myelin pallor loss of synaptic density and neuronal cell loss, mainly in the hippocampus. [Pg.607]

Aylward EH, Brettschneider PD, McArthur JC, Harris GJ, Sch-laepfer TE, Henderer JD, Barta PE, Tien AY, Pearlson GD (1995) Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia. Am J Psychiatry 152 987-994. [Pg.617]

Power C, Seines OA, Grim JA, McArthur JC (1995) HIV Dementia Scale A rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol 8 273-278. [Pg.618]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...